These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20302817)

  • 1. NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.
    Ramsey AJ
    Prog Brain Res; 2009; 179():51-8. PubMed ID: 20302817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
    Moy SS; Perez A; Koller BH; Duncan GE
    Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
    Enomoto T; Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.
    Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH
    Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
    J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
    Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
    Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique.
    Nagy GG; Watanabe M; Fukaya M; Todd AJ
    Eur J Neurosci; 2004 Dec; 20(12):3301-12. PubMed ID: 15610162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the N-methyl-D-aspartate receptor NR1 subunit in peripheral nerve injury-induced mechanical allodynia, glial activation and chemokine expression in the mouse.
    Bursztajn S; Rutkowski MD; Deleo JA
    Neuroscience; 2004; 125(1):269-75. PubMed ID: 15051165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
    Halene TB; Ehrlichman RS; Liang Y; Christian EP; Jonak GJ; Gur TL; Blendy JA; Dow HC; Brodkin ES; Schneider F; Gur RC; Siegel SJ
    Genes Brain Behav; 2009 Oct; 8(7):661-75. PubMed ID: 19563516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypoglutamatergic hypothesis of schizophrenia: evidence from genetic studies].
    Itokawa M; Yoshikawa T
    Seishin Shinkeigaku Zasshi; 2003; 105(11):1349-62. PubMed ID: 14758783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM; Chergui K
    J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia.
    Labrie V; Roder JC
    Neurosci Biobehav Rev; 2010 Mar; 34(3):351-72. PubMed ID: 19695284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient global ischemia in rat brain promotes different NMDA receptor regulation depending on the brain structure studied.
    Dos-Anjos S; Martínez-Villayandre B; Montori S; Regueiro-Purriños MM; Gonzalo-Orden JM; Fernández-López A
    Neurochem Int; 2009; 54(3-4):180-5. PubMed ID: 19103243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
    Baier PC; Blume A; Koch J; Marx A; Fritzer G; Aldenhoff JB; Schiffelholz T
    Behav Brain Res; 2009 Dec; 205(1):96-101. PubMed ID: 19539658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
    Laruelle M; Frankle WG; Narendran R; Kegeles LS; Abi-Dargham A
    Clin Ther; 2005; 27 Suppl A():S16-24. PubMed ID: 16198197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
    Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
    J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
    Rujescu D; Bender A; Keck M; Hartmann AM; Ohl F; Raeder H; Giegling I; Genius J; McCarley RW; Möller HJ; Grunze H
    Biol Psychiatry; 2006 Apr; 59(8):721-9. PubMed ID: 16427029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.